TGex is a powerful, easy to use, full flow NGS Analysis and Interpretation platform. Powered by the GeneCardsSuite, it offers rapid biological interpretation & prioritization, automated evidence-driven reports, and is available on cloud or on premises.
Effectively navigate the universe of biological entities - genes, proteins, cells, biological pathways and diseases, and the connections between them.
20 January 2016
LifeMap Sciences, Inc. (“LifeMap”), a life sciences technology company and subsidiary of BioTime, Inc., announced today the market launch of TGex™ (Translational Genomics Expert), an integrated next-generation genomic sequencing (NGS) analysis platform. TGex leverages the GeneCards Suite Knowledgebase to rapidly identify genetic variants that may impact disease management and health outcomes, eliminating a traditional research bottleneck and enabling streamlined, efficient exploration and utilization of sequencing data for research, as well as exploring diagnostic and therapeutic utility in the rapidly growing, global NGS market. TGex™ was developed in partnership with Toldot Genetics, LTD (Toldot), a subsidiary of BATM Advanced Communications, Ltd.Read more